Results 181 to 190 of about 20,808 (296)

Therapeutic targeting of the eIF4E cap-binding domain reveals control of lineage fate in prostate cancer. [PDF]

open access: yesJ Clin Invest
Mishra R   +18 more
europepmc   +1 more source

Follicular Keratinization

open access: yesJournal of Investigative Dermatology, 1974
openaire   +2 more sources

Tongue and Glottis Morphology of Cathartes aura and the Secret of Its Functional Adaptation

open access: yesActa Zoologica, EarlyView.
ABSTRACT Cathartes aura, commonly known as the Turkey vulture, is a scavenger bird belonging to the family Cathartidae that is widely distributed throughout the Americas and classified as a New World vulture. Its diet primarily consists of small‐sized carcasses, predominantly of wild animals.
Jean Caio Figueiredo de Almeida   +5 more
wiley   +1 more source

A luminal non‐coding RNA‐based genomic classifier confirms favourable outcomes in patients with clinically organ‐confined bladder cancer treated with radical cystectomy

open access: yesBJU International, Volume 135, Issue 4, Page 648-656, April 2025.
Objective To further evaluate a genomic classifier (GC) in a cohort of patients undergoing radical cystectomy (RC), as long non‐coding RNA (lncRNA)‐based genomic profiling has suggested utility in identifying a distinct tumour subgroup corresponding to a favourable prognosis in patients with bladder cancer.
Joep J. de Jong   +14 more
wiley   +1 more source

Brain metastasis‐associated fibroblasts shape the tumour microenvironment to enhance cancer cell invasion

open access: yesBrain Pathology, EarlyView.
Brain metastasis‐associated fibroblasts are active stromal components of the metastatic niche characterised by extracellular matrix remodelling and production of pro‐migratory mediators. They promote monocyte and cancer cell migration and enhance cancer cell invasion while having no growth‐promoting effect on cancer cells.
Barbora Výmolová   +19 more
wiley   +1 more source

Targeting KRAS for cancer therapy

open access: yesBritish Journal of Pharmacology, EarlyView.
In recent years, therapeutics targeted against KRAS proto‐oncogene GTPase (KRAS)‐mutant cancers have seen significant progress. Herein we outline the biology and epidemiology of KRAS alterations at the lineage and allele levels, reviewing the clinical evidence for KRASG12C inhibition from the discovery of the recessive switch pocket to sotorasib ...
Jianlong Jia   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy